Atopic Dermatitis Studies through In Vitro Models
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Atopic dermatitis (AD) is a complex inflammatory skin condition that is not fully understood. Epidermal barrier defects and Th2 immune response dysregulations are thought to play crucial roles in the pathogenesis of the disease. A vicious circle takes place between these alterations and it can further be complicated by additional genetic and environmental factors. Studies investigating in depth the aetiology of the disease are thus needed in order to develop functional treatments. In recent years there have been significant advances regarding in vitro models reproducing important features of AD. However, since a lot of models have been developed, finding the appropriate experimental settings can be puzzling. Therefore, we herein review several types of in vitro skin models mimicking features of AD. Most simple models are two-dimensional culture systems composed of immune cells or keratinocytes, whereas three-dimensional skin or epidermal equivalents reconstitute more complex stratified tissues exhibiting functional barrier properties. In latter models, several hallmarks of AD can be obtained, either by challenging tissues with cocktails of interleukins overexpressed in AD epidermis, or by silencing expression of pivotal genes encoding epidermal barrier proteins. Tissue equivalents co-cultured with lymphocytes or containing AD patient cells are also discussed. Furthermore, each model is placed in the context of a specific study with a brief summary of main results obtained so far. In conclusion, AD in vitro models may become increasingly useful tools to better understand AD pathogenesis, but also to potentially screen new curative or preventive treatments for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978 · cited 4×
“Clin Exp Allergy (2011) 41(11):1515–20.”
BackgroundInfluentialLiang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 2×
“Further interesting, IL-17 and IL-22 could act synergistically to regulate notably gene expression of AMPs (128) and S. aureus, that frequently affects AD patients, could induce production of Th17 cells (129).”
BackgroundNew insights into atopic dermatitis
Leung, D. Y. M., Boguniewicz, M., Howell, M. D., Nomura, I., & Hamid, Q. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21060 · Cited by 1,435
Gittler, J. K., Shemer, A., Suárez-Fariñas, M., Fuentes-Duculan, J., Gulewicz, K. J., Wang, C. Q. F., Mitsui, H., Cardinale, I., de Guzman Strong, C., Krueger, J. G., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.012 · Cited by 981 · cited 1×
“However, situation is probably more complicated as small increases in Th1 and Th17 are also found in acute lesions while a progressive activation of Th2 and Th22 cells would also characterize the chronic phase of the disease (58).”
BackgroundPathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., & Sallusto, F. (2012) · Nature · doi:10.1038/nature10957 · Cited by 919
Boniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., & Morel, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3695 · Cited by 864
Skin pH: from basic science to basic skin care
Ali, S., & Yosipovitch, G. (2013) · Acta Dermato Venereologica · doi:10.2340/00015555-1531 · Cited by 690
Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J. G., & Guttman-Yassky, E. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.041 · Cited by 627 · cited 1×
“Regarding Th22 cells, these are also reported as increased in AD skin and correlated with disease severity (126).”
BackgroundThymic stromal lymphopoietin: master switch for allergic inflammation
Liu, Y.-J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051745 · Cited by 576
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538
Schmook, F. P., Meingassner, J. G., & Billich, A. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00665-7 · Cited by 529
Eckhart, L., Lippens, S., Tschachler, E., & Declercq, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.010 · Cited by 515
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis
Guttman-Yassky, E., Suárez-Fariñas, M., Chiricozzi, A., Nograles, K. E., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Lin, P., Bergman, R., Bowcock, A. M., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.031 · Cited by 268
Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin
Pellerin, L., Henry, J., Hsu, C.-Y., Balica, S., Jean-Decoster, C., Méchin, M.-C., Hansmann, B., Rodriguez, E., Weindinger, S., Schmitt, A.-M., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1566 · Cited by 239 · cited 5×
“Indeed, IL-4, IL-13, IL-22, and IL-25 are all able to downregulate expression of differentiation markers such as FLG (19, 22, 24, 86).”
BackgroundInfluentialIncreased number of immunoreactive nerve fibers in atopic dermatitis
Tobin, D., Nabarro, G., de la Faute, H. B., van Vloten, W. A., van der Putte, S. C. J., & Schuurman, H.-J. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90134-n · Cited by 211 · cited 3×
“In the other procedure described by Engelhart and his colleagues (94), the whole HSE was transferred onto a collagen matrix containing the lymphocytes, coated with cell-free collagen mixture that acts as an adhesive for the HSE.”
BackgroundMethodHall, J. M. F., Cruser, D., Podawiltz, A., Mummert, D. I., Jones, H., & Mummert, M. E. (2012) · Dermatology Research and Practice · doi:10.1155/2012/403908 · Cited by 178
Gutowska-Owsiak, D., Schaupp, A. L., Salimi, M., Taylor, S., & Ogg, G. S. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10400.x · Cited by 168
Cited by
Dijkhoff, I. M., Drasler, B., Karakocak, B. B., Petri-Fink, A., Valacchi, G., Eeman, M., & Rothen-Rutishauser, B. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00366-y · Cited by 202
Skin microbiota and human 3D skin models
Rademacher, F., Simanski, M., Gläser, R., & Harder, J. (2018) · Experimental Dermatology · doi:10.1111/exd.13517 · Cited by 64
In Vitro and Ex Vivo Models for Screening Topical Anti-Inflammatory Drugs
Pérez-Salas, J. L., Moreno-Jiménez, M. R., Rocha-Guzmán, N. E., González-Laredo, R. F., Medina-Torres, L., & Gallegos-Infante, J. A. (2023) · Scientia Pharmaceutica · doi:10.3390/scipharm91020020 · Cited by 22
Increase in primary cilia in the epidermis of patients with atopic dermatitis and psoriasis
Rizaldy, D., Toriyama, M., Kato, H., Fukui, R., Fujita, F., Nakamura, M., Okada, F., Morita, A., & Ishii, K. J. (2021) · Experimental Dermatology · doi:10.1111/exd.14285 · Cited by 17
Metadata
- Authors
- De Vuyst, E., Salmon, M., Evrard, C., Lambert de Rouvroit, C., & Poumay, Y.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2017-07-24
- Volume
- 4
- Pages
- 119-119
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W2739240705
- Cited by
- 77
- References
- 17
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.